Skip to main content
Figure 2 | Trials

Figure 2

From: Feasibility of omega-3 fatty acid supplementation as an adjunct therapy for people with chronic obstructive pulmonary disease: study protocol for a randomized controlled trial

Figure 2

The proposed relationship between omega-3 fatty acid supplementation mechanisms and outcomes of interest. 6MWD, six minute walk distance; CRQ, chronic respiratory questionnaire; FEF25-75, forced expiratory flow between 25 and 75% of forced vital capacity; HADS, hospital anxiety and depression scale; IOS, impulse oscillometry; PUFA, polyunsaturated fatty acid.

Back to article page